Journal
FRONTIERS IN MEDICINE
Volume 8, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fmed.2021.655268
Keywords
mesenchymal stem cells; liver diseases; mechanism; efficacy; safety
Categories
Funding
- National Key Research and Development Program of China [2016YFC 1101304/3]
Ask authors/readers for more resources
Mesenchymal stem cell (MSC) transplantation is a novel treatment for liver diseases, but the mechanisms are not fully understood. Despite significant efficacy in animal models and preliminary clinical trials, issues such as efficacy and safety remain. Therefore, more research is needed to address the challenging issues of MSC-based therapy in the treatment of liver diseases.
Mesenchymal stem cell (MSC) transplantation is a novel treatment for liver diseases due to the roles of MSCs in regeneration, fibrosis inhibition and immune regulation. However, the mechanisms are still not completely understood. Despite the significant efficacy of MSC therapy in animal models and preliminary clinical trials, issues remain. The efficacy and safety of MSC-based therapy in the treatment of liver diseases remains a challenging issue that requires more investigation. This article reviews recent studies on the mechanisms of MSCs in liver diseases and the associated challenges and suggests potential future applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available